Projection of the total costs of breast cancer treatment excluding and including the values of fixed assets from the year 2021 to 2025.

Estimated median (range) number of years for each cancer type to progress from one stage to the next.

Lee Schwartzberg (56360)
Michael S. Broder (4056544)
Sikander Ailawadhi (718783)
Himisha Beltran (5779568)
L. Johnetta Blakely (14290167)
G. Thomas Budd (11218723)
Laurie Carr (14290170)
Michael Cecchini (14290173)
Patrick Cobb (14290176)
Anuraag Kansal (14290179)
Ashley Kim (5100917)
Bradley J. Monk (13849592)
Deborah J. Wong (12076528)
Cynthia Campos (14290182)
Irina Yermilov (5929432)

December 2022

Estimated median (range) number of years for each cancer type to progress from one stage to the next...

Total drug cost estimation in active treatment period and post-active treatment period.

Alfredo Palacios (7316909)
Natalia Espinola (9189954)
Juan Martin Gonzalez (17735858)
Carlos Rojas-Roque (9189957)
Maria Marta Rivas (17735861)
Diego Kanevski (17735864)
Pierre Morisset (17735867)
Federico Augustovski (752120)
Andres Pichon-Riviere (217543)
Ariel Bardach (202568)

January 2024

Total drug cost estimation in active treatment period and post-active treatment period.</p

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP).

Thomas Grochtdreis (741198)
Hans-Helmut König (63648)
Alexander Dobruschkin (6054080)
Gunhild von Amsberg (2862761)
Judith Dams (6054083)

December 2018

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP)....

Cumulative breast cancer treatment costs by stages of in situ, local, regional and distant.

Li Sun (4624)
Rosa Legood (362486)
Isabel dos-Santos-Silva (528117)
Shivani Mathur Gaiha (6009653)
Zia Sadique (3487259)

November 2018

Cumulative breast cancer treatment costs by stages of in situ, local, regional and distant.</p

Basic characteristics and cumulative breast cancer treatment costs by stage (US dollars in 2015).

Li Sun (4624)
Rosa Legood (362486)
Isabel dos-Santos-Silva (528117)
Shivani Mathur Gaiha (6009653)
Zia Sadique (3487259)

November 2018

Basic characteristics and cumulative breast cancer treatment costs by stage (US dollars in 2015).</p

Comparison of breast cancer treatment costs between current practice and NCCN guidance (as of April 21, 2020).

Tamiru Demeke (9713827)
Wondimu Ayele (4782537)
Damen Haile Mariam (7348952)
Andreas Wienke (2152522)
Mathewos Assefa (4097167)
Adamu Addissie (3180735)
Rafael Mikolajczyk (43665)
Susanne Unverzagt (301872)
Eva Johanna Kantelhardt (4683103)

October 2022

Comparison of breast cancer treatment costs between current practice and NCCN guidance (as of April ...

The absolute health expenditures of women with breast cancer (costs in 2010 euros).

Emil Victor Gruber (294993)
Stephanie Stock (294994)
Björn Stollenwerk (294995)

February 2013

The absolute health expenditures of women with breast cancer (costs in 2010 euros).</p

Cumulative outpatient main healthcare care costs since the index dates in different health states of HER2-positive breast cancer in Iran, during a 3-year follow-up period (21.3.2011–20.3.2014).

Amir Ansaripour (5807627)
Kazem Zendehdel (731058)
Niki Tadayon (5807630)
Fatemeh Sadeghi (832474)
Carin A. Uyl-de Groot (4370503)
W. Ken Redekop (5807633)

October 2018

Cumulative outpatient main healthcare care costs since the index dates in different health states of...

Costs (in billions of €) in selected years of simulation, for individual disease stages and no change in treatment (reference simulations).

Richard Cimler (6264623)
Petra Maresova (5534255)
Jitka Kuhnova (6264626)
Kamil Kuca (1474993)

January 2019

Costs (in billions of €) in selected years of simulation, for individual disease stages and no chang...

Estimated costs to reach pre-defined baselines by 2020 for each knowledge product.

Diego Juffe-Bignoli (2966925)
Thomas M. Brooks (161133)
Stuart H. M. Butchart (104981)
Richard B. Jenkins (2966964)
Kaia Boe (2966916)
Michael Hoffmann (177395)
Ariadne Angulo (421026)
Steve Bachman (2966970)
Monika Böhm (264487)
Neil Brummitt (2966919)
Kent E. Carpenter (152167)
Pat J. Comer (2966922)
Neil Cox (377741)
Annabelle Cuttelod (2966952)
William R. T. Darwall (2966955)
Moreno Di Marco (588249)
Lincoln D. C. Fishpool (177373)
Bárbara Goettsch (2966943)
Melanie Heath (2966931)
Craig Hilton-Taylor (57131)
Jon Hutton (583823)
Tim Johnson (100663)
Ackbar Joolia (2966958)
David A. Keith (411219)
Penny F. Langhammer (469319)
Jennifer Luedtke (2966934)
Eimear Nic Lughadha (709386)
Maiko Lutz (781061)
Ian May (177411)
Rebecca M. Miller (2966961)
María A. Oliveira-Miranda (411240)
Mike Parr (177426)
Caroline M. Pollock (2966910)
Gina Ralph (2966949)
Jon Paul Rodríguez (411220)
Carlo Rondinini (34027)
Jane Smart (2966928)
Simon Stuart (2966913)
Andy Symes (2966937)
Andrew W. Tordoff (2966946)
Stephen Woodley (177444)
Bruce Young (2966967)
Naomi Kingston (2966940)

August 2016

Estimated costs to reach pre-defined baselines by 2020 for each knowledge product.</p

Estimated workload for the breast, cervical, oral, and lung cancer for the next 15 years (2022–37).

Hemant Mahajan (16378728)
Neha Reddy (16548725)
N. G. Marina Devi (16548728)
Usha Rani Poli (16548731)
M Jayaram (13482925)
Shailaja Tetali (335234)
G. V. S. Murthy (3143685)

July 2023

Estimated workload for the breast, cervical, oral, and lung cancer for the next 15 years (2022–37).<...

Total 2013/14 expenditure by modelled disease (£000s except cost per prevalent case).

Adam D. M. Briggs (5278952)
Peter Scarborough (329722)
Jane Wolstenholme (398829)

May 2018

Total 2013/14 expenditure by modelled disease (£000s except cost per prevalent case).</p

Boxplot of cancer treatment cost by diagnosis for 161 children at Bugando Medical Centre from January 2010 to August 2014.

Anthony T. Saxton (3281109)
Manisha Bhattacharya (14142015)
Dharshan Sivaraj (14142018)
Henry E. Rice (3281124)
Nestory Masalu (8633634)
Nelson J. Chao (9368078)
Kristin Schroeder (699838)

November 2022

Boxplot of cancer treatment cost by diagnosis for 161 children at Bugando Medical Centre from Januar...

Total and average costs of treating analytical cohort for CIN 2+ (US$ 2015) (Functional Limit scenario), intention-to-treat analysis.

Naomi Lince-Deroche (700158)
Craig van Rensburg (3157011)
Jaqueline Roseleur (5848118)
Busola Sanusi (5848121)
Jane Phiri (827350)
Pam Michelow (289529)
Jennifer S. Smith (283828)
Cindy Firnhaber (387170)

October 2018

Total and average costs of treating analytical cohort for CIN 2+ (US$ 2015) (Functional Limit scenar...

Summary of costs for cases and controls (based on predicted costs from modelling output).

Janet Bouttell (3269616)
James Lewsey (820080)
Claudia Geue (839106)
Grace Antony (3269622)
Andrew Briggs (279327)
Gerry McCartney (151772)
Sharon Hutchinson (839109)
Lesley Graham (3269619)
Mathis Heydtmann (820078)

October 2016

Summary of costs for cases and controls (based on predicted costs from modelling output).</p

Estimated median (range) number of years for each cancer type to progress from one stage to the next.

Lee Schwartzberg (56360)
Michael S. Broder (4056544)
Sikander Ailawadhi (718783)
Himisha Beltran (5779568)
L. Johnetta Blakely (14290167)
G. Thomas Budd (11218723)
Laurie Carr (14290170)
Michael Cecchini (14290173)
Patrick Cobb (14290176)
Anuraag Kansal (14290179)
Ashley Kim (5100917)
Bradley J. Monk (13849592)
Deborah J. Wong (12076528)
Cynthia Campos (14290182)
Irina Yermilov (5929432)

December 2022

Estimated median (range) number of years for each cancer type to progress from one stage to the next...

Total drug cost estimation in active treatment period and post-active treatment period.

Alfredo Palacios (7316909)
Natalia Espinola (9189954)
Juan Martin Gonzalez (17735858)
Carlos Rojas-Roque (9189957)
Maria Marta Rivas (17735861)
Diego Kanevski (17735864)
Pierre Morisset (17735867)
Federico Augustovski (752120)
Andres Pichon-Riviere (217543)
Ariel Bardach (202568)

January 2024

Total drug cost estimation in active treatment period and post-active treatment period.</p

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP).

Thomas Grochtdreis (741198)
Hans-Helmut König (63648)
Alexander Dobruschkin (6054080)
Gunhild von Amsberg (2862761)
Judith Dams (6054083)

December 2018

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP)....

Cumulative breast cancer treatment costs by stages of in situ, local, regional and distant.

Li Sun (4624)
Rosa Legood (362486)
Isabel dos-Santos-Silva (528117)
Shivani Mathur Gaiha (6009653)
Zia Sadique (3487259)

November 2018

Cumulative breast cancer treatment costs by stages of in situ, local, regional and distant.</p

Basic characteristics and cumulative breast cancer treatment costs by stage (US dollars in 2015).

Li Sun (4624)
Rosa Legood (362486)
Isabel dos-Santos-Silva (528117)
Shivani Mathur Gaiha (6009653)
Zia Sadique (3487259)

November 2018

Basic characteristics and cumulative breast cancer treatment costs by stage (US dollars in 2015).</p

Comparison of breast cancer treatment costs between current practice and NCCN guidance (as of April 21, 2020).

Tamiru Demeke (9713827)
Wondimu Ayele (4782537)
Damen Haile Mariam (7348952)
Andreas Wienke (2152522)
Mathewos Assefa (4097167)
Adamu Addissie (3180735)
Rafael Mikolajczyk (43665)
Susanne Unverzagt (301872)
Eva Johanna Kantelhardt (4683103)

October 2022

Comparison of breast cancer treatment costs between current practice and NCCN guidance (as of April ...

The absolute health expenditures of women with breast cancer (costs in 2010 euros).

Emil Victor Gruber (294993)
Stephanie Stock (294994)
Björn Stollenwerk (294995)

February 2013

The absolute health expenditures of women with breast cancer (costs in 2010 euros).</p

Cumulative outpatient main healthcare care costs since the index dates in different health states of HER2-positive breast cancer in Iran, during a 3-year follow-up period (21.3.2011–20.3.2014).

Amir Ansaripour (5807627)
Kazem Zendehdel (731058)
Niki Tadayon (5807630)
Fatemeh Sadeghi (832474)
Carin A. Uyl-de Groot (4370503)
W. Ken Redekop (5807633)

October 2018

Cumulative outpatient main healthcare care costs since the index dates in different health states of...

Costs (in billions of €) in selected years of simulation, for individual disease stages and no change in treatment (reference simulations).

Richard Cimler (6264623)
Petra Maresova (5534255)
Jitka Kuhnova (6264626)
Kamil Kuca (1474993)

January 2019

Costs (in billions of €) in selected years of simulation, for individual disease stages and no chang...

Estimated costs to reach pre-defined baselines by 2020 for each knowledge product.

Diego Juffe-Bignoli (2966925)
Thomas M. Brooks (161133)
Stuart H. M. Butchart (104981)
Richard B. Jenkins (2966964)
Kaia Boe (2966916)
Michael Hoffmann (177395)
Ariadne Angulo (421026)
Steve Bachman (2966970)
Monika Böhm (264487)
Neil Brummitt (2966919)
Kent E. Carpenter (152167)
Pat J. Comer (2966922)
Neil Cox (377741)
Annabelle Cuttelod (2966952)
William R. T. Darwall (2966955)
Moreno Di Marco (588249)
Lincoln D. C. Fishpool (177373)
Bárbara Goettsch (2966943)
Melanie Heath (2966931)
Craig Hilton-Taylor (57131)
Jon Hutton (583823)
Tim Johnson (100663)
Ackbar Joolia (2966958)
David A. Keith (411219)
Penny F. Langhammer (469319)
Jennifer Luedtke (2966934)
Eimear Nic Lughadha (709386)
Maiko Lutz (781061)
Ian May (177411)
Rebecca M. Miller (2966961)
María A. Oliveira-Miranda (411240)
Mike Parr (177426)
Caroline M. Pollock (2966910)
Gina Ralph (2966949)
Jon Paul Rodríguez (411220)
Carlo Rondinini (34027)
Jane Smart (2966928)
Simon Stuart (2966913)
Andy Symes (2966937)
Andrew W. Tordoff (2966946)
Stephen Woodley (177444)
Bruce Young (2966967)
Naomi Kingston (2966940)

August 2016

Estimated costs to reach pre-defined baselines by 2020 for each knowledge product.</p

Estimated workload for the breast, cervical, oral, and lung cancer for the next 15 years (2022–37).

Hemant Mahajan (16378728)
Neha Reddy (16548725)
N. G. Marina Devi (16548728)
Usha Rani Poli (16548731)
M Jayaram (13482925)
Shailaja Tetali (335234)
G. V. S. Murthy (3143685)

July 2023

Estimated workload for the breast, cervical, oral, and lung cancer for the next 15 years (2022–37).<...

Total 2013/14 expenditure by modelled disease (£000s except cost per prevalent case).

Adam D. M. Briggs (5278952)
Peter Scarborough (329722)
Jane Wolstenholme (398829)

May 2018

Total 2013/14 expenditure by modelled disease (£000s except cost per prevalent case).</p

Boxplot of cancer treatment cost by diagnosis for 161 children at Bugando Medical Centre from January 2010 to August 2014.

Anthony T. Saxton (3281109)
Manisha Bhattacharya (14142015)
Dharshan Sivaraj (14142018)
Henry E. Rice (3281124)
Nestory Masalu (8633634)
Nelson J. Chao (9368078)
Kristin Schroeder (699838)

November 2022

Boxplot of cancer treatment cost by diagnosis for 161 children at Bugando Medical Centre from Januar...

Total and average costs of treating analytical cohort for CIN 2+ (US$ 2015) (Functional Limit scenario), intention-to-treat analysis.

Naomi Lince-Deroche (700158)
Craig van Rensburg (3157011)
Jaqueline Roseleur (5848118)
Busola Sanusi (5848121)
Jane Phiri (827350)
Pam Michelow (289529)
Jennifer S. Smith (283828)
Cindy Firnhaber (387170)

October 2018

Total and average costs of treating analytical cohort for CIN 2+ (US$ 2015) (Functional Limit scenar...

Summary of costs for cases and controls (based on predicted costs from modelling output).

Janet Bouttell (3269616)
James Lewsey (820080)
Claudia Geue (839106)
Grace Antony (3269622)
Andrew Briggs (279327)
Gerry McCartney (151772)
Sharon Hutchinson (839109)
Lesley Graham (3269619)
Mathis Heydtmann (820078)

October 2016

Summary of costs for cases and controls (based on predicted costs from modelling output).</p

Estimated median (range) number of years for each cancer type to progress from one stage to the next.

Lee Schwartzberg (56360)
Michael S. Broder (4056544)
Sikander Ailawadhi (718783)
Himisha Beltran (5779568)
L. Johnetta Blakely (14290167)
G. Thomas Budd (11218723)
Laurie Carr (14290170)
Michael Cecchini (14290173)
Patrick Cobb (14290176)
Anuraag Kansal (14290179)
Ashley Kim (5100917)
Bradley J. Monk (13849592)
Deborah J. Wong (12076528)
Cynthia Campos (14290182)
Irina Yermilov (5929432)

December 2022

Estimated median (range) number of years for each cancer type to progress from one stage to the next...

Total drug cost estimation in active treatment period and post-active treatment period.

Alfredo Palacios (7316909)
Natalia Espinola (9189954)
Juan Martin Gonzalez (17735858)
Carlos Rojas-Roque (9189957)
Maria Marta Rivas (17735861)
Diego Kanevski (17735864)
Pierre Morisset (17735867)
Federico Augustovski (752120)
Andres Pichon-Riviere (217543)
Ariel Bardach (202568)

January 2024

Total drug cost estimation in active treatment period and post-active treatment period.</p

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP).

Thomas Grochtdreis (741198)
Hans-Helmut König (63648)
Alexander Dobruschkin (6054080)
Gunhild von Amsberg (2862761)
Judith Dams (6054083)

December 2018

Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP)....

Projection of the total costs of breast cancer treatment excluding and including the values of fixed assets from the year 2021 to 2025.

Abstract

Extracted data

Projection of the total costs of breast cancer treatment excluding and including the values of fixed assets from the year 2021 to 2025.

Abstract

Extracted data

Related items

Related items